Magenta Therapeutics H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Cambridge, MA HQ🌐 magentatx.com
Does Magenta Therapeutics sponsor H-1B visas?
Yes. Magenta Therapeutics has filed 15 H-1B LCAs with the U.S. Department of Labor between FY2018 and FY2026. In FY2023 Magenta Therapeutics filed 3 H-1B LCAs at a median base salary of $108,420, about 2% below the national H-1B median of $110,447 for the same period. No PERM green-card cases are on record.
Cambridge, MA accounts for 100% of its H-1B filings.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2023 | 3 | $108k |
| FY2022 | 5 | $84k |
| FY2021 | 2 | $96k |
| FY2020 | 1 | $68k |
| FY2019 | 3 | $64k |
| FY2018 | 1 | $55k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Research Associate3$64k
- 2Associate Director, Bioanalysis Leader2$171k
- 3Analytics and Automation Development Engineer1$111k
- 4Associate Scientist1$84k
- 5Research Associate II1$55k
- 6Research Associate, In Vitro Biology/Biochemistry1$59k
- 7Research Associate, In Vitro Biology (Cellular/Molecular)1$62k
- 8Scientific Project Lead, Biochemistry1$108k
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds aren’t available.
Patents
- Granted
- 15
- US patents
- Published, not yet granted
- 62
- applications
- Most recent grant
- February 7, 2023
- Top area
- Preparations for medical10
About Magenta Therapeutics
Magenta Therapeutics is a pharma & biotech company based in Cambridge, MA. It is listed on Nasdaq as DNTH.
- Legal name
- Dianthus Therapeutics, Inc. /DE/
- Listed
- Nasdaq: DNTH
- Incorporated in
- Delaware
- Headquarters
- 7 Times Square, New York, NY 10036
- Industry
- Pharma & biotech
- Website
- magentatx.com
- Revenue FY2025
- $2M -67% from $6M
- Net income FY2025
- $-162M -91% from $-85M
- R&D FY2025
- $146M (7153% of revenue)
H-1B sponsors similar to Magenta Therapeutics
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Aera Therapeutics | 16 | 10 | $92k | 8 | — |
| Eureka Therapeutics | 16 | 3 | $142k | 0 | — |
| Imanis Life Sciences | 16 | 10 | $69k | 10 | — |
| Magenta Therapeutics | 15 | 0 | — | 0 | — |
| Adimab Service Company | 15 | 7 | $146k | 5 | — |
| Colossal Biosciences | 15 | 4 | $128k | 2 | — |
| Particle Sciences | 15 | 7 | $82k | 2 | — |
